CXCR4 mRNA expression was 3.9-fold higher in patients with slight hearing loss (H1/2), 4.6-fold higher in patients with moderate hearing impairment (H3/4), and 5-fold higher in patients with severe hearing loss or deafness (H5/6) compared to the control group. Here, CXCR4 is linked to Hearing impairment.